Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations

https://ift.tt/CiS5r43

Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations

from Sanofi - Aventis Groupe https://ift.tt/KuHyDeS
via IFTTT